Notes on Lai Chin personal pronouns and overt case marking

published or submitted for publicationis peer reviewe

Lai v. Wei

USDC for the District of New Jerse

Photoproduction of W Bosons at HERA: Reweighting Method for implementing QCD Corrections in Monte Carlo Programs

A procedure of implementing QCD corrections in Monte Carlo programs by a reweighting method is described for the photoproduction of W bosons at HERA. Tables for W boson production in LO and NLO are given in bins of the transverse momentum of the W boson and its rapidity.Comment: 39 pages, latex, 5 figure

Recent LAI PD VSM Research

Overview • LAI PDVSM 1.0 released • Predecessors in widespread (?) distribution and use (??) in the LAI consortium • Several recent research projects completed using value stream mapping in PD • Kato—Waste in PD • Whitaker—VSM and EVMS • MacKenzie—VSM in USAF SPOs • Evidence of significant PDVSM activities among LAI consortium members • Where do we stand as a learning community? • What are the next steps

Long-term schizophrenia treatment — solutions for new challenges

W 2002 roku wprowadzono do praktyki leczenie za pomocą leków długodziałających II generacji. Mimo dowodów na skuteczność i bezpieczeństwo terapii (opartych na badaniach naukowych i widocznych w praktyce), nie jest ona często stosowana. Istnieje wiele przeszkód — przede wszystkim percepcja psychiatrów, którzy nie są wystarczająco przekonani do leków LAI, a także pacjentów, którzy zazwyczaj obawiają się bólu i iniekcji. Wynik 6-letniego badania obserwacyjnego dotyczącego olanzapiny LAI pokazuje, że terapia może trwać wiele lat i jest skuteczna, co więcej — bezpieczna w tak długim okresie obserwacji.Since 2002 long acting injectable (LAI) antipsychotics are available in the treatment of patients with the diagnosis of schizophrenia. Despite their efficacy and good tolerability demonstrated in numerous studies and in clinical practice, LAI antipsychotics are still under-used. Among main obstacles to its more frequent use the crucial ones are: negative or ambivalent perception of this class of medications by psychiatrists and patients anxieties connected with injection and expected pain. The results of the 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia provides evidence for the conclusion that olanzapine LAI is effective in long term maintenance treatment with good safety profile consistent with the known profile of oral olanzapine